E Voog
Overview
Explore the profile of E Voog including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourgeois H, Grude F, Solal-Celigny P, Dupuis O, Voog E, Ganem G, et al.
Ann Oncol
. 2017 May;
28(7):1612-1617.
PMID: 28472235
Background: In 2008, a study of the characteristics of hospitalised patients led to the development of a prognostic tool that distinguished three populations with significantly different 2-month survival rates. The...
2.
Magrangeas F, Avet-Loiseau H, Gouraud W, Lode L, Decaux O, Godmer P, et al.
Leukemia
. 2012 Aug;
27(2):473-81.
PMID: 22874878
Recent studies have provided direct evidence for genetic variegation in subclones for various cancer types. However, little is known about subclonal evolutionary processes according to treatment and subsequent relapse in...
3.
Gross-Goupil M, Fourcade A, Blot E, Penel N, Negrier S, Culine S, et al.
Eur J Cancer
. 2012 Feb;
48(5):721-7.
PMID: 22317952
Purpose: To compare the overall survival rates of good-prognosis carcinomas of an unknown primary site (CUPS) patients treated with cisplatin alone (C) or in combination with gemcitabine (CG). Patients And...
4.
Fizazi K, de Bono J, Flechon A, Heidenreich A, Voog E, Davis N, et al.
Eur J Cancer
. 2011 Dec;
48(1):85-93.
PMID: 22129890
Purpose: This open-label phase II trial assessed mitoxantrone/prednisone (M/P) with and without siltuximab (CNTO 328), an anti-interleukin-6 chimeric monoclonal antibody, for patients with metastatic castration-resistant prostate cancer who received prior...
5.
Kerbrat P, Lhomme C, Fervers B, Guastalla J, Thomas L, Basuyau J, et al.
Gynecol Obstet Fertil
. 2002 Jan;
29(11):853-66.
PMID: 11770281
No abstract available.
6.
Voog E, Le Q, Philip I, Benetaib B, Michallet M, Fiere D, et al.
Ann Hematol
. 2001 Dec;
80(10):584-91.
PMID: 11732869
In order to determine whether granulocyte colony-stimulating factor (G-CSF) alone initiated during steady state was able to mobilize peripheral blood stem cells (PBSC) in acute myeloid leukemia (AML) and to...
7.
Kerbrat P, Lhomme C, Fervers B, Guastalla J, Thomas L, Basuyau J, et al.
Gynecol Obstet Fertil
. 2001 Dec;
29(10):733-42.
PMID: 11732441
No abstract available.
8.
Kerbrat P, Lhomme C, Fervers B, Guastalla J, Thomas L, Tournemaine N, et al.
Br J Cancer
. 2001 May;
84 Suppl 2:18-23.
PMID: 11355964
No abstract available.
9.
Voog E, Merrouche Y, Trillet-Lenoir V, Lasset C, Peaud P, Rebattu P, et al.
Am J Clin Oncol
. 2001 Feb;
23(6):614-6.
PMID: 11202809
The aim of this study was to determine the efficacy and toxicity of combination cisplatin and etoposide chemotherapy in patients with metastatic carcinoma of unknown primary. Patients were treated with...
10.
Sellgren U, Voog E, Zoger S
Lakartidningen
. 2000 Dec;
97(46):5343-5.
PMID: 11116874
No abstract available.